escharex
Biologicalexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2014 (NCT02020746)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- escharex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06690177 | Phase 2 | Apr 30, 2025 | MediWound Ltd |
| NCT06568627 | Phase 3 | Nov 30, 2024 | MediWound Ltd |
| NCT05157763 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2021 | MediWound Ltd |
| NCT04817228 | Phase 2 | Apr 21, 2021 | MediWound Ltd |
| NCT03588130 | Phase 2 | Aug 31, 2018 | MediWound Ltd |
| NCT02020746 | Phase 2 | Aug 1, 2014 | MediWound Ltd |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MediWound Ltd | For profit | 6 | 6 | 2 | 2014 |
1 organizations
Page 1 / 1